A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
about
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmPrimary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgeryAntiplatelet and anticoagulation for patients with prosthetic heart valvesAntiplatelet and anticoagulation for patients with prosthetic heart valvesVTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesManagement of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillationIncreased platelet reactivity and significant changes in coagulation markers after cavopulmonary connectionAntiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmAcute coronary embolism: angiographic diagnosis and treatment with primary angioplastyThe nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillationShould aspirin be continued in patients started on warfarin?Ocular bleeding related to warfarin anticoagulation in patients with mechanical heart valve and atrial fibrillationCollaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' CollaborationThrombotic obstruction of a mechanical prosthetic valve in tricuspid position.Anticoagulant therapy of pregnant patients with prosthetic heart valves: rationale for a clinical trial of low molecular weight heparin.Oral anticoagulant treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complications.Diamond-like carbon coating and plasma or glow discharge treatment of mechanical heart valves.Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery.Intracerebral haemorrhages and oral anticoagulation in the north of Scotland.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial.CSI consensus statement on prosthetic valve follow upAntithrombotic therapy in patients with prosthetic heart valvesAre acute subdural hematomas possible without head trauma?Current status of anticoagulation and thrombosis-related issues in mechanical valves.Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesEffect of age on international normalized ratio at the time of major bleeding in patients treated with warfarin.Anticoagulation in pregnant women with prosthetic heart valves.Interaction of warfarin with drugs, natural substances, and foods.Cardiovascular manifestations of hypereosinophilic syndromes.Challenges in managing anticoagulant therapy in patients with heart valve prostheses.Systemic thromboembolism leading to myocardial infarction and stroke after fenestrated total cavopulmonary connection.Family planning requirements in the adult congenital heart disease clinicInsulin dependent diabetes in nonagenariansAntithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician.Pregnancy in women with prosthetic heart valvesA 44-year experience of prosthetic heart valve implantation at Niigata University Hospital.Antithrombotic therapy for patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention: a review.The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties.
P2860
Q24185800-54557C86-0C14-46E7-BB84-BD0D6C18DE53Q24187077-373CF43D-E4EA-424D-9501-5D4ACDE6BBCEQ24201287-F2189A2B-803D-4D64-B00D-3F162FD22EECQ24247784-9B8BA709-A495-49B8-9165-E92A0414AF88Q24632982-2F08497B-683C-4088-B7EE-D91A1F2E2837Q28167261-583F4A72-9D6E-425D-8BEE-A74438A25891Q28174739-2861E23D-6063-4C7D-9297-FE74D2B8E65CQ28191116-24EC915C-BBCB-4D83-9B1A-9B043026B46DQ28192763-BEFB9409-3F38-4AFC-90E4-BD210797CFBBQ28194361-6D0FCD4C-FB92-4504-9807-5A2FF0E2A6EDQ28199065-1D86B089-37CA-4FCF-9177-A77732C7BC67Q28222062-F4CC57FE-07CD-4B8F-8127-DF55D542F788Q29619529-CAC8C8C3-E2B1-4046-9D7F-A4AC6348C9FDQ30488226-C4F30548-5BA8-4B19-A193-7E4C2773BD41Q33331821-3BDB7EA4-7C92-4A80-B068-F4FD41A8F1B3Q33651497-FD8080CD-E490-4E06-81C0-7A8304190E26Q33696565-1A97863A-9C8D-49BA-AEB5-24A3205611E8Q34065069-7AD0B0F2-7C80-4C9B-B975-E11A260B0AFEQ34075223-ACE9E40E-5E31-4BAF-9853-2B3312C921FDQ34252907-F41A938C-3580-41A7-AD43-50D6F658EF75Q34262668-D3A61CF8-AF3F-48B2-B24A-8269A9A214D6Q34574855-644FC20D-EA57-49F6-8B94-A9B1795CA3A9Q34735887-9F61D369-10CA-415A-B2D0-8252ECD81BE2Q35071311-BBB4D4DA-E68D-400F-8747-C0B06047A628Q35658054-7B122EF1-BA25-46AE-A926-AD2B9964F17DQ35752576-E0ACB309-2B7D-4108-93D7-D04FC893021BQ35752619-2C0CDDD6-01D5-46EE-99DD-A103DDFC418AQ35783707-824C4A9E-7989-4875-A147-87E97DF5CB58Q35862159-2F836075-8DB9-4B5A-9EE5-84C783779BB2Q36007599-72594C7F-3294-465A-9897-3654C87368EBQ36102877-D2EF0130-EDBA-4BD1-B90F-0BA8C1ABC385Q36815991-85162DF4-4542-4DB7-8A94-32E5DB5BE6D0Q36818971-404BCD6D-AF59-42ED-B77F-839A8EAB1992Q36833567-C30CF314-9131-4642-9E32-4010A0CBC063Q36903361-AA59D504-255C-4B2B-98AA-82D644D9F763Q36975515-0BEC739E-4092-4AEC-9586-A55EF057CA2CQ37032720-B7A98916-E267-4751-BF29-1097CF1A09C4Q38004960-020CE48A-169F-43B5-8AA8-DB5BFAFBF7D1Q38108234-ABB3E08A-A250-4037-9B61-0E7F383263A5Q38247892-0815339E-5181-421A-A513-FC4867E8B525
P2860
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
name
A comparison of aspirin with p ...... after heart-valve replacement.
@ast
A comparison of aspirin with p ...... after heart-valve replacement.
@en
A comparison of aspirin with p ...... after heart-valve replacement.
@nl
type
label
A comparison of aspirin with p ...... after heart-valve replacement.
@ast
A comparison of aspirin with p ...... after heart-valve replacement.
@en
A comparison of aspirin with p ...... after heart-valve replacement.
@nl
prefLabel
A comparison of aspirin with p ...... after heart-valve replacement.
@ast
A comparison of aspirin with p ...... after heart-valve replacement.
@en
A comparison of aspirin with p ...... after heart-valve replacement.
@nl
P2093
P921
P1476
A comparison of aspirin with p ...... after heart-valve replacement.
@en
P2093
Gunstensen J
Laupacis A
P304
P356
10.1056/NEJM199308193290802
P407
P577
1993-08-01T00:00:00Z